ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,585
0,00%
Bitcoin
60 975,51
0,29%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Avadel Pharmaceuticals PLC (AVDL)

  7. Avadel Pharmaceuticals PLC (AVDL) Actualités

AVDL

Avadel Pharmaceuticals (AVDL)

Avadel Pharmaceuticals PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AVDL
DateHeureSourceTitreSymboleSociété
08/05/202422h17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/05/202422h06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:AVDLAvadel Pharmaceuticals PLC
08/05/202415h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVDLAvadel Pharmaceuticals PLC
08/05/202414h29IH Market NewsU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices FallNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/05/202413h00GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
01/05/202414h00GlobeNewswire Inc.Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8NASDAQ:AVDLAvadel Pharmaceuticals PLC
01/04/202414h00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare ConferenceNASDAQ:AVDLAvadel Pharmaceuticals PLC
05/03/202414h00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:AVDLAvadel Pharmaceuticals PLC
04/03/202421h37GlobeNewswire Inc.Avadel Pharmaceuticals Issues Statement On Patent LitigationNASDAQ:AVDLAvadel Pharmaceuticals PLC
04/03/202412h30GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
04/03/202412h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
26/02/202414h00GlobeNewswire Inc.Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4NASDAQ:AVDLAvadel Pharmaceuticals PLC
14/02/202413h11Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVDLAvadel Pharmaceuticals PLC
13/02/202415h40Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AVDLAvadel Pharmaceuticals PLC
07/02/202414h00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/01/202413h00GlobeNewswire Inc.Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Quarter and Full Year 2023 Financial HighlightsNASDAQ:AVDLAvadel Pharmaceuticals PLC
28/12/202320h54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/11/202313h00GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
30/10/202313h00GlobeNewswire Inc.Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on November 8NASDAQ:AVDLAvadel Pharmaceuticals PLC
20/10/202314h00GlobeNewswire Inc.Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ (sodium oxybate) for extended-release oral suspension (CIII) at World Sleep 2023NASDAQ:AVDLAvadel Pharmaceuticals PLC
05/10/202314h00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at the Jefferies Biotech CNS/Neuro SummitNASDAQ:AVDLAvadel Pharmaceuticals PLC
09/08/202313h00GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
03/08/202322h05GlobeNewswire Inc.Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
02/08/202314h00GlobeNewswire Inc.Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter Financial Results on August 9NASDAQ:AVDLAvadel Pharmaceuticals PLC
23/06/202321h05Dow Jones NewsAvadel Pharmaceuticals to Intervene in Jazz Pharmaceuticals Lawsuit Over FDA RulingNASDAQ:AVDLAvadel Pharmaceuticals PLC
23/06/202318h12Dow Jones NewsAvadel ADRs Tumble 14% Following Lawsuit Trying to Overturn FDA Approval of Similar DrugNASDAQ:AVDLAvadel Pharmaceuticals PLC
23/06/202300h59Dow Jones NewsJazz Pharmaceuticals Files Complaint Against FDA for Decision on Avadel Pharmaceuticals' LumryzNASDAQ:AVDLAvadel Pharmaceuticals PLC
22/06/202314h00GlobeNewswire Inc.Avadel Pharmaceuticals to Host Commercial Day on June 29 for LUMRYZ™ (sodium oxybate) extended release for oral solution, CIIINASDAQ:AVDLAvadel Pharmaceuticals PLC
14/06/202314h00GlobeNewswire Inc.Avadel Pharmaceuticals Sponsors the Academy of Sleep Medicine Foundation’s 2023 Young Investigators Research ForumNASDAQ:AVDLAvadel Pharmaceuticals PLC
13/06/202314h00GlobeNewswire Inc.Avadel Pharmaceuticals Announces Publication of Study Data in Advances in Therapy Highlighting Need for Once-at-Bedtime Oxybate Dosing for NarcolepsyNASDAQ:AVDLAvadel Pharmaceuticals PLC
 Showing the most relevant articles for your search:NASDAQ:AVDL

Dernières Valeurs Consultées

COIN
OPENETH
OPEN Governance Token
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés